1
|
Lin YY, Cho SF. Occult scar carcinoma of the lung with overt liver metastases and high serum CA 19-9 levels. J Postgrad Med 2019; 65:251-252. [PMID: 31611432 PMCID: PMC6813679 DOI: 10.4103/jpgm.jpgm_145_19] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
Affiliation(s)
- Y Y Lin
- Department of Preventive Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
| | - S F Cho
- Division of Hematology and Oncology, Department of Internal Medicine, Kaohsiung Medical University Hospital, Kaohsiung Medical University, Kaohsiung, Taiwan
| |
Collapse
|
2
|
Hsiao HH, Liu YC, Wang HC, Tsai YF, Wu CH, Cho SF, Hsu JF, Huang CT, Hsiao SY, Lee CP, Chang CS, Lin SF, Liu TC. Additional chromosomal abnormalities in core-binding factor acute myeloid leukemia. Genet Mol Res 2015; 14:17028-33. [PMID: 26681050 DOI: 10.4238/2015.december.16.3] [Citation(s) in RCA: 6] [Impact Index Per Article: 0.7] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/03/2022]
Abstract
Despite sharing a similar genetic abnormality, patients with core binding factor acute myeloid leukemia (CBF-AML), which is characterized by the presence of t(8;21) or inv(16)/t(16;16), show heterogeneous survival. Other molecular or cytogenetic factors are supposed to have an impact on the prognosis. We enrolled 24 CBF-AML patients to determine the impact of cytogenetic abnormality, and c-KIT, FLT3, NPM1, and CEBPA mutations on the prognosis. Only three patients had the c-KIT mutation (3/24, 12.5%) and one had the FLT3 mutation. However, over half of the patients (14/24) harbored additional cytogenetic changes, including ten with loss of sexual chromosomes (LOS) [all in the t(8;21) group], and six had additional abnormalities (two cases had both LOS and additional abnormalities). From this small-number study, no association was found between c-KIT mutation and survival and relapse rate. However, additional chromosome abnormalities had a significant association with relapse of the disease (P = 0.027). Stem cell transplant had a trend of benefitting patients after relapse (P = 0.065). This implies that chromosome abnormalities occur in CBF-AML and might take part in the heterogeneous nature of CBF-AML.
Collapse
Affiliation(s)
- H H Hsiao
- Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung, Taiwan.,Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.,Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
| | - Y C Liu
- Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung, Taiwan.,Department of Medical Research, Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
| | - H C Wang
- Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung, Taiwan
| | - Y F Tsai
- Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung, Taiwan
| | - C H Wu
- Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung, Taiwan
| | - S F Cho
- Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung, Taiwan
| | - J F Hsu
- Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung, Taiwan
| | - C T Huang
- Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung, Taiwan
| | - S Y Hsiao
- Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung, Taiwan
| | - C P Lee
- Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung, Taiwan
| | - C S Chang
- Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung, Taiwan.,Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
| | - S F Lin
- Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung, Taiwan.,Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
| | - T C Liu
- Division of Hematology-Oncology, Department of Internal Medicine, Kaohsiung, Taiwan.,Department of Laboratory Kaohsiung Medical University Hospital, Kaohsiung, Taiwan.,Faculty of Medicine, College of Medicine, Kaohsiung Medical University, Kaohsiung, Taiwan
| |
Collapse
|
3
|
Hsiao HH, Liu YC, Wang HC, Wu CH, Cho SF, Hsu JF, Tsai HJ, Hsiao S, Chang CS, Lin SF, Liu TC, Chuang WL, Yu ML. Hepatitis C transmission from viremic donors in hematopoietic stem cell transplant. Transpl Infect Dis 2014; 16:1003-6. [PMID: 25367218 DOI: 10.1111/tid.12306] [Citation(s) in RCA: 11] [Impact Index Per Article: 1.1] [Reference Citation Analysis] [What about the content of this article? (0)] [Affiliation(s)] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/21/2014] [Revised: 06/30/2014] [Accepted: 08/12/2014] [Indexed: 01/04/2023]
Affiliation(s)
- H.-H. Hsiao
- Division of Hematology/Oncology; Department of Internal Medicine; Kaohsiung Medical University Hospital; Kaohsiung Taiwan
- Faculty of Internal Medicine; College of Medicine; Kaohsiung Medical University; Kaohsiung Taiwan
| | - Y.-C. Liu
- Division of Hematology/Oncology; Department of Internal Medicine; Kaohsiung Medical University Hospital; Kaohsiung Taiwan
- Faculty of Internal Medicine; College of Medicine; Kaohsiung Medical University; Kaohsiung Taiwan
| | - H.-C. Wang
- Division of Hematology/Oncology; Department of Internal Medicine; Kaohsiung Medical University Hospital; Kaohsiung Taiwan
| | - C.-H. Wu
- Division of Hematology/Oncology; Department of Internal Medicine; Kaohsiung Medical University Hospital; Kaohsiung Taiwan
| | - S.-F. Cho
- Division of Hematology/Oncology; Department of Internal Medicine; Kaohsiung Medical University Hospital; Kaohsiung Taiwan
| | - J.-F. Hsu
- Division of Hematology/Oncology; Department of Internal Medicine; Kaohsiung Medical University Hospital; Kaohsiung Taiwan
| | - H.-J. Tsai
- Division of Hematology/Oncology; Department of Internal Medicine; Kaohsiung Medical University Hospital; Kaohsiung Taiwan
| | - S.Y. Hsiao
- Division of Hematology/Oncology; Department of Internal Medicine; Kaohsiung Medical University Hospital; Kaohsiung Taiwan
| | - C.-S. Chang
- Division of Hematology/Oncology; Department of Internal Medicine; Kaohsiung Medical University Hospital; Kaohsiung Taiwan
- Faculty of Internal Medicine; College of Medicine; Kaohsiung Medical University; Kaohsiung Taiwan
| | - S.-F. Lin
- Division of Hematology/Oncology; Department of Internal Medicine; Kaohsiung Medical University Hospital; Kaohsiung Taiwan
- Faculty of Internal Medicine; College of Medicine; Kaohsiung Medical University; Kaohsiung Taiwan
| | - T.-C. Liu
- Division of Hematology/Oncology; Department of Internal Medicine; Kaohsiung Medical University Hospital; Kaohsiung Taiwan
- Faculty of Internal Medicine; College of Medicine; Kaohsiung Medical University; Kaohsiung Taiwan
| | - W.-L. Chuang
- Faculty of Internal Medicine; College of Medicine; Kaohsiung Medical University; Kaohsiung Taiwan
- Hepatobiliary Division; Department of Internal Medicine; Kaohsiung Medical University Hospital; Kaohsiung Taiwan
| | - M.-L. Yu
- Faculty of Internal Medicine; College of Medicine; Kaohsiung Medical University; Kaohsiung Taiwan
- Hepatobiliary Division; Department of Internal Medicine; Kaohsiung Medical University Hospital; Kaohsiung Taiwan
| |
Collapse
|